The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising development. Unlike injections, this method offers a simpler way to provide GLP-1 therapies. These https://matteovkoo283885.blogs100.com/41369543/glp-1-patches-a-new-approach-to-blood-sugar-management